Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis (Q33950106)

30 July 2017

Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis (English)

1 reference

pulmonary alveolar proteinosis

30 July 2017

1 reference

1 reference

17

Konosuke Morimoto

1 reference

30 July 2017

2

Bruce C Trapnell

1 reference

30 July 2017

Ryushi Tazawa

1

1 reference

30 July 2017

Yoshikazu Inoue

3

1 reference

30 July 2017

Toru Arai

4

1 reference

30 July 2017

Toshinori Takada

5

1 reference

30 July 2017

Yasuyuki Nasuhara

6

1 reference

30 July 2017

Nobuyuki Hizawa

7

1 reference

30 July 2017

Yasunori Kasahara

8

1 reference

30 July 2017

Koichiro Tatsumi

9

1 reference

30 July 2017

Masayuki Hojo

10

1 reference

30 July 2017

Haruyuki Ishii

11

1 reference

30 July 2017

Masanori Yokoba

12

1 reference

30 July 2017

Naohiko Tanaka

13

1 reference

30 July 2017

Etsuro Yamaguchi

14

1 reference

30 July 2017

Ryosuke Eda

15

1 reference

30 July 2017

Yoshiko Tsuchihashi

16

1 reference

30 July 2017

Masanori Akira

18

1 reference

30 July 2017

Masaki Terada

19

1 reference

30 July 2017

Junji Otsuka

20

1 reference

30 July 2017

Masahito Ebina

21

1 reference

30 July 2017

Chinatsu Kaneko

22

1 reference

30 July 2017

Toshihiro Nukiwa

23

1 reference

30 July 2017

Jeffrey P Krischer

24

1 reference

30 July 2017

Kohei Akazawa

25

1 reference

30 July 2017

Koh Nakata

26

1 reference

30 July 2017

language of work or name

English

0 references

publication date

18 February 2010

1 reference

American Journal of Respiratory and Critical Care Medicine

30 July 2017

1 reference

30 July 2017

181

1 reference

30 July 2017

12

1 reference

30 July 2017

1345-1354

1 reference

A dose-escalation study of aerosolized sargramostim in the treatment of metastatic melanoma: an NCCTG Study

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894410

Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894410

Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894410

GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894410

An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894410

Pulmonary alveolar proteinosis: progress in the first 44 years

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894410

Non-specific interstitial pneumonia: findings on sequential CT scans of nine patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894410

Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894410

Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894410

Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894410

Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2894410

Pulmonary Alveolar Proteinosis

5 July 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0978OC

High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0978OC

Lung lavage (alveolar washing) in alveolar proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0978OC

Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0978OC

Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0978OC

GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0978OC

Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0978OC

Quantitative analysis of longitudinal response to aerosolized granulocyte-macrophage colony-stimulating factor in two adolescents with autoimmune pulmonary alveolar proteinosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200906-0978OC

Aerosol granulocyte macrophage-colony stimulating factor: a low toxicity, lung-specific biological therapy in patients with lung metastases

21 January 2018

1 reference

12 December 2020

Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis

1 reference

12 December 2020

A combination therapy of whole lung lavage and GM-CSF inhalation in pulmonary alveolar proteinosis

1 reference

12 December 2020

Accounting for radioactivity before and after nebulization of tobramycin to insure accuracy of quantification of lung deposition

1 reference

12 December 2020

Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis

1 reference

12 December 2020

Pulmonary alveolar proteinosis

1 reference

12 December 2020

Pulmonary alveolar proteinosis. Xe-133 scintigraphic findings before and after bronchopulmonary lavage

1 reference

12 December 2020

Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice

1 reference

12 December 2020

10.1164/RCCM.200906-0978OC

Identifiers

DOI

1 reference

release_5njgh4nyuvgbphx42ovflq7muq

30 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5njgh4nyuvgbphx42ovflq7muq

24 November 2022

mapped directly with Wikidata item

PMCID

2894410

1 reference

30 July 2017

1 reference